Ipamorelin is a selective growth hormone secretagogue, categorized under growth hormone peptides. This synthetic peptide is designed to stimulate the secretion of growth hormone (GH) from the pituitary gland, making it a significant compound in research related to growth hormone regulation and its effects on various physiological processes.
As a pentapeptide, Ipamorelin is known for its specificity in targeting growth hormone release without significantly affecting other hormones. Its unique structure allows it to mimic ghrelin, a natural hormone that plays a crucial role in appetite regulation and energy balance.
Ipamorelin operates through a specific mechanism that involves binding to the growth hormone secretagogue receptor (GHS-R). This interaction triggers a cascade of biological responses that lead to increased secretion of growth hormone from the anterior pituitary.
The peptide's selective action minimizes the release of other hormones, such as cortisol and prolactin, which can be associated with other growth hormone secretagogues. This selectivity is one of the reasons why Ipamorelin is of interest in research settings focused on optimizing growth hormone levels without unwanted side effects.
Ipamorelin is a selective growth hormone secretagogue that plays a vital role in the regulation of growth hormone release. Its targeted action and minimal side effects make it a valuable subject of research in understanding growth hormone's physiological impacts.
Last updated: Jan 8, 2026